195 related articles for article (PubMed ID: 27267136)
1. Effect of Mutation and Substrate Binding on the Stability of Cytochrome P450BM3 Variants.
Geronimo I; Denning CA; Rogers WE; Othman T; Huxford T; Heidary DK; Glazer EC; Payne CM
Biochemistry; 2016 Jun; 55(25):3594-606. PubMed ID: 27267136
[TBL] [Abstract][Full Text] [Related]
2. Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450
Geronimo I; Denning CA; Heidary DK; Glazer EC; Payne CM
Biophys J; 2018 Oct; 115(7):1251-1263. PubMed ID: 30224054
[TBL] [Abstract][Full Text] [Related]
3. Hoodwinking Cytochrome P450BM3 into Hydroxylating Non-Native Substrates by Exploiting Its Substrate Misrecognition.
Shoji O; Aiba Y; Watanabe Y
Acc Chem Res; 2019 Apr; 52(4):925-934. PubMed ID: 30888147
[TBL] [Abstract][Full Text] [Related]
4. P450
Beyer N; Kulig JK; Bartsch A; Hayes MA; Janssen DB; Fraaije MW
Appl Microbiol Biotechnol; 2017 Mar; 101(6):2319-2331. PubMed ID: 27900443
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3).
Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z
Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374
[TBL] [Abstract][Full Text] [Related]
6. Novel haem co-ordination variants of flavocytochrome P450BM3.
Girvan HM; Toogood HS; Littleford RE; Seward HE; Smith WE; Ekanem IS; Leys D; Cheesman MR; Munro AW
Biochem J; 2009 Jan; 417(1):65-76. PubMed ID: 18721129
[TBL] [Abstract][Full Text] [Related]
7. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
8. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
9. Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.
Spradlin J; Lee D; Mahadevan S; Mahomed M; Tang L; Lam Q; Colbert A; Shafaat OS; Goodin D; Kloos M; Kato M; Cheruzel LE
Biochim Biophys Acta; 2016 Dec; 1864(12):1732-1738. PubMed ID: 27639964
[TBL] [Abstract][Full Text] [Related]
10. Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.
Butler CF; Peet C; Mason AE; Voice MW; Leys D; Munro AW
J Biol Chem; 2013 Aug; 288(35):25387-25399. PubMed ID: 23828198
[TBL] [Abstract][Full Text] [Related]
11. Expanding the applicability of cytochrome P450s and other haemoproteins.
Ariyasu S; Stanfield JK; Aiba Y; Shoji O
Curr Opin Chem Biol; 2020 Dec; 59():155-163. PubMed ID: 32781431
[TBL] [Abstract][Full Text] [Related]
12. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
Huang WC; Cullis PM; Raven EL; Roberts GC
Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial alanine substitution enables rapid optimization of cytochrome P450BM3 for selective hydroxylation of large substrates.
Lewis JC; Mantovani SM; Fu Y; Snow CD; Komor RS; Wong CH; Arnold FH
Chembiochem; 2010 Dec; 11(18):2502-5. PubMed ID: 21108271
[TBL] [Abstract][Full Text] [Related]
14. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
[TBL] [Abstract][Full Text] [Related]
15. Role of the linker region connecting the reductase and heme domains in cytochrome P450BM-3.
Govindaraj S; Poulos TL
Biochemistry; 1995 Sep; 34(35):11221-6. PubMed ID: 7669780
[TBL] [Abstract][Full Text] [Related]
16. Improving the activity of cytochrome P450 BM-3 catalyzing indole hydroxylation by directed evolution.
Pengpai Z; Sheng H; Lehe M; Yinlin L; Zhihua J; Guixiang H
Appl Biochem Biotechnol; 2013 Sep; 171(1):93-103. PubMed ID: 23817788
[TBL] [Abstract][Full Text] [Related]
17. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
Cha GS; Ryu SH; Ahn T; Yun CH
Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
[TBL] [Abstract][Full Text] [Related]
18. Exploring PTDH-P450BM3 Variants for the Synthesis of Drug Metabolites.
Beyer N; Kulig JK; Fraaije MW; Hayes MA; Janssen DB
Chembiochem; 2018 Feb; 19(4):326-337. PubMed ID: 29181885
[TBL] [Abstract][Full Text] [Related]
19. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
20. Crystals in Minutes: Instant On-Site Microcrystallisation of Various Flavours of the CYP102A1 (P450BM3) Haem Domain.
Stanfield JK; Omura K; Matsumoto A; Kasai C; Sugimoto H; Shiro Y; Watanabe Y; Shoji O
Angew Chem Int Ed Engl; 2020 May; 59(19):7611-7618. PubMed ID: 32157795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
